GeniusVac Mel4Alternative Names: GeniusVacMel4; PDC*mel
Latest Information Update: 25 May 2016
At a glance
- Originator PDC*line Pharma
- Developer PDC*line Pharma; University Hospital Grenoble
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Malignant melanoma
Most Recent Events
- 23 May 2016 Phase-I development is ongoing in France